The patient journey leaked people at every stage rather than at one obvious failure point. Activation instructions confused the company's older core users from the very first step, which meant some patients never got as far as collecting a sample at all. A process meant to feel reassuring instead felt uncertain from the moment the kit arrived.

Once a sample was posted, it effectively vanished. Nothing told a patient their sample had been received, was being processed, or was on track for a result, so patients were left waiting with no sense of whether anything was actually happening. A meaningful share of shipped kits were never returned at all, meaning the uncertainty of the early steps carried all the way through to patients simply not finishing the process.

Results, when they arrived, did not resolve the anxiety the journey had built. A dense portal PDF is not how most patients want to receive a health result, and predictably it triggered anxious support calls from people who could not easily interpret what they were reading. The company had built a good diagnostic and wrapped it in a patient experience that undermined trust at nearly every step.

We mapped the full patient journey end to end before redesigning anything, so we could see how confusion at activation, silence after posting, and anxiety at results were connected rather than three separate problems. We then ran 4 rounds of moderated usability testing with the company's older core demographic, the group the original journey served worst.

Every touchpoint was redesigned around the same principle: never leave a patient guessing. Activation became a step-by-step flow with photographic cues rather than text alone, a live kit-status tracker replaced the silence after posting, and an SMS reminder cadence kept patients moving without needing them to remember on their own. Results screens were rewritten in plain language together with the clinical team, so a result could inform rather than alarm.